Starai meglio Solito ascia gabriella farina fatebenefratelli cantante fuga portatile
Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients - Journal of Thoracic Oncology
The prognostic role of tumor size in early breast cancer in the era of molecular biology | PLOS ONE
Diapositiva 1
FORMATO EUROPEO PER IL CURRICULUM VITAE
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of Oncology
ASST Fatebenefratelli & SACCO | ESMO
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations
20+ "Gabriella Farina" profiles | LinkedIn
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence
Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients | PLOS ONE
Il caregiver in oncologia: una guida per sostenere il malato | Fondazione Aiom
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer
La Rete locale di Cure Palliative di Milano
20+ "Gabriella Farina" profiles | LinkedIn
Gabriella e la squadra con 70 donne «La nostra sfida ai tumori» - Corriere.it
Nutrients | Free Full-Text | The Role of Nutritional Support for Cancer Patients in Palliative Care | HTML
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial - ESMO Open
Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before and during Active Cancer Treatment | HTML
Presentazione standard di PowerPoint
Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study - The Breast
Sabato 7 Aprile corso Unitalsi: "la fine della vita" - CiaoComo
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer